Grant Details

General Overview

Grant Information

Funding Organization: National Institutes of Health (NIH)

Total Funding Amount: Up to $275,000 over two years

Primary Objective: Advance research on schizophrenia and related disorders in mid- to late-life

Key Stakeholders: Researchers, individuals with schizophrenia, healthcare providers

Funding Source: Federal government

Grant Frequency: Recurring

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions

Private Institutions

Nonprofits (with and without 501(c)(3) status)

For-Profit Organizations

Small Businesses

Local, State, County, City Governments

Indian/Native American Tribal Governments

Federal Agencies

Foreign Organizations

Specific Qualifications

All applicants must have an eRA Commons account

Registration in System for Award Management (SAM) is required

Scope and Focus

Primary Focus Areas

Research on mechanisms underlying schizophrenia and related disorders

Studies targeting individuals aged 35 and above

Research addressing health disparities in minority populations

Expected Outcomes

Identification of novel prevention and treatment targets

Improved understanding of the trajectory of schizophrenia in mid- to late-life

Technical Details

Technical Expertise Requirements

Teams should include expertise from neuroscience, psychology, pharmacology, and related fields

Encouragement for teams led by individuals with lived experience of psychosis

Financial Structure

Budget Limitations

Maximum budget: $275,000 over two years

Maximum annual request: $200,000

Timeline and Implementation

Submission Deadlines

Application Due Date: June 16, 2026

Multiple submission dates leading up to this deadline

Compliance and Requirements

Regulatory Compliance

Must adhere to NIH Grants Policy Statement

Compliance with human subjects protection regulations

Application Process

Required Documentation

Follow the instructions in the How to Apply - Application Guide

Applications must be submitted electronically

Grant Details

schizophrenia mental health psychotic disorders aging health disparities research clinical trials neuroscience psychology biomedical research
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
PAR-25-040
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH OTHER
US
HEALTHCARE RESEARCH
DEVELOPMENT
OTHER
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
275000.00
None
275000.00
USD
None
June 16, 2026, 10 p.m.
Not specified